FNY Investment Advisers’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Hold
14,000
﹤0.01% 829
2026
Q1
$1K Hold
14,000
﹤0.01% 737
2025
Q4
$1K Sell
14,000
-100
-0.7% -$7 ﹤0.01% 870
2025
Q3
$0 Buy
14,100
+100
+0.7% ﹤0.01% 1592
2025
Q2
$5K Sell
14,000
-700
-5% -$250 ﹤0.01% 754
2025
Q1
$2K Buy
14,700
+500
+4% +$68 ﹤0.01% 658
2024
Q4
$3K Buy
14,200
+400
+3% +$85 ﹤0.01% 575
2024
Q3
$4K Hold
13,800
﹤0.01% 578
2024
Q2
$4K Hold
13,800
﹤0.01% 382
2024
Q1
$4 Buy
+13,800
New +$59.4K ﹤0.01% 545
2022
Q2
Sell
-800
Closed -$2K 967
2022
Q1
$2K Buy
+800
New +$3.3K ﹤0.01% 648

FNY Investment Advisers's LIAN Position: Q2 2026 in Review

FNY Investment Advisers held its LianBio American Depositary Shares (LIAN) position steady in Q2 2026 at 14,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #829.

FNY Investment Advisers first reported a position in LIAN in Q1 2022 and has held it in 11 quarters since. The position peaked at $5K in Q2 2025. 1 fund tracked by Wall St. Rank holds LIAN as of Q2 2026.

  • FNY Investment Advisers held 14,000 shares of LianBio American Depositary Shares worth $1K as of Q2 2026.
  • FNY Investment Advisers left its LianBio American Depositary Shares share count unchanged in Q2 2026.
  • LianBio American Depositary Shares made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #829 holding.
  • FNY Investment Advisers first reported a position in LianBio American Depositary Shares in Q1 2022 and has held it in 11 quarters since.
  • FNY Investment Advisers's LianBio American Depositary Shares position peaked at $5K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held LianBio American Depositary Shares as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.